Developer docs
API playgroundTry for free, no card

Search company profiles

NowRx

Full company profile

uuid0000dps

Namestring
NowRx
Legal namestring
Nowrx
Websiteurl
nowrx.com
Company typeenum
Private
Founded yearint
2016
Descriptiontext

NowRx was a digital pharmacy and last-mile logistics company founded in 2015 in Mountain View, California, that provided same-day and same-hour prescription medication delivery to individual consumers. The company combined a licensed pharmacy operation with proprietary delivery infrastructure, enabling direct-to-consumer fulfillment of prescriptions without requiring patients to visit a brick-and-mortar location. Its product portfolio comprised a core prescription delivery service and a Telehealth Service launched in 2021 that enabled virtual healthcare consultations, which experienced 1,200% growth in its first year. The technology platform integrated prescription management, telehealth consultations, and health information content delivery to consumers.

The company operated a direct-to-consumer go-to-market motion, targeting individual healthcare consumers seeking convenience over traditional pharmacy channels. Its revenue model was built on prescription fulfillment fees and telehealth service subscriptions. NowRx raised over $43 million in total funding primarily through equity crowdfunding on SeedInvest, with a Series C round of $18.6 million closed in May 2022 from over 6,100 retail investors. The company grew from $600,000 in revenue in 2016 to over $20 million by 2022, reaching 51-100 employees.

In November 2022, NowRx was acquired by Alto Pharmacy, a competing digital pharmacy, ending its independent operations. Multiple securities class action lawsuits filed in 2025 allege that NowRx concealed material adverse financial information, including near-bankruptcy and reduced valuation, from investors during its February-November 2022 Series C offering period.

Short descriptiontext

NowRx was a Mountain View-based digital pharmacy offering same-day prescription delivery and telehealth services to individual healthcare consumers, having raised over $43 million via equity crowdfunding before being acquired by Alto Pharmacy in November 2022.

Operating statusenum
Acquired
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersMountain View, United States
HQ citystring
Mountain View
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
prescription delivery, digital pharmacy, telehealth services, same-day delivery, online pharmacy
Industry3 codes
PRIMARYHLALABAL
Virtual Pharmacy & Medication Management Integration Platforms
Healthcare & Life Sciences/Telehealth Platforms/Provider-Integrated Virtual Care Platforms (Health Systems/Clinics)
SECONDARYHLALAAAD
Prescription-Based Digital Clinics (Condition-Specific Rx Programs)
Healthcare & Life Sciences/Telehealth Platforms/Direct-to-Consumer Virtual Care Platforms
SECONDARYHLACAKAG
Specialty Pharmacy & Complex Therapy Management Platforms
Healthcare & Life Sciences/Digital Health & Health IT/ePrescribing, Medication Management & Pharmacy IT
Product category
Digital Pharmacy and Prescription Delivery Services
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Prescription Pharmacy Services
TypeSubscription Recurring
Description

Traditional pharmacy prescription fulfillment and delivery services to consumers

crowdfundinsider.com
2Telehealth Services
TypeSubscription Recurring
Description

Virtual healthcare consultations and services, experienced 1,200% growth in 2021

crowdfundinsider.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Marketing or Sales, Technology or R&D, Supply Chain
GTM typeB2C
B2C
Offering typeServices
Services
Core offering1 text field

NowRx is a digital pharmacy and last-mile logistics company that provides same-day and same-hour prescription medication delivery directly to consumers. The company also operates a telehealth service enabling virtual healthcare consultations and prescription management, and publishes health information content covering medications, conditions, and wellness topics.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Revenue growth from $600,000 to over $20 million since 2016
+1 more record
Product overview1 text field

NowRx operates primarily as a health information platform that provides educational content about medications, health conditions, and pharmacy services through its website. The platform publishes health articles and wellness guidance covering topics such as medication management, natural remedies, prescription refills, and various health conditions. The company also offers a telehealth service that launched in 2021 and experienced significant growth, enabling remote healthcare consultations. The product portfolio consists of the core health information website and the telehealth service offering.

Product and service3 records
1NowRx Prescription Delivery Service
CategoryPharmacy and prescription delivery services
Description

Same-day and same-hour prescription medication delivery service providing direct-to-consumer home delivery of prescription medications, eliminating the need to visit a traditional brick-and-mortar pharmacy. Targeted at individual healthcare consumers seeking fast, accurate, and convenient prescription fulfillment.

2NowRx Telehealth Service
CategoryTelehealth and virtual healthcare services
Description

Telehealth service platform that enables remote virtual healthcare consultations and prescription management, providing a seamless digital experience that integrates with NowRx's prescription delivery offering. Designed for individual consumers needing virtual care and prescription access.

3NowRx Health Information Platform
CategoryHealth information and content
Description

Health information and insights platform publishing educational articles about medications, health conditions, wellness topics, natural remedies, and pharmacy services. Targeted at individual healthcare consumers seeking trusted health information and expert insights.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierMinorTypeOthers
Description

NowRx was acquired by Alto Pharmacy, a digital pharmacy company, announced in late 2022 period following the Series C offering and associated legal disputes.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Major US retail pharmacy with same-day prescription delivery in many markets — large incumbent competitor in pharmacy fulfillment with far greater scale and capital.

TypeEmerging player
Description

Digital pharmacy offering prescription discounts and home delivery — comparable DTC prescription delivery and online pharmacy positioning.

TypeDirect peer
Description

Digital-first pharmacy offering free same-day delivery and a mobile-first prescription management experience; competes head-to-head with NowRx for DTC prescription customers in major US metros.

TypeBroad incumbent
Description

Amazon's mail-order pharmacy service (including PillPack), providing prescription delivery at scale with Prime integration — a much larger incumbent pursuing the same digital pharmacy opportunity as NowRx.

TypeDirect peer
Description

Acquirer of NowRx and a leading venture-backed digital pharmacy offering same-day delivery, pharmacist consultations, and integrated prescription management — directly comparable business model, customer base, and last-mile delivery infrastructure.

TypeEmerging player
Description

Digital pharmacy and telehealth infrastructure platform serving D2C health brands with fulfillment, telehealth, and pharmacy APIs — overlapping with NowRx's pharmacy + telehealth integration thesis.

TypeDirect peer
Description

Digital pharmacy providing free same-day prescription delivery and telehealth-style pharmacist consultations in select US markets — closely comparable DTC model and customer experience to NowRx.

8CVS Pharmacy
TypeBroad incumbent
Description

Largest US retail pharmacy chain with home delivery and digital prescription services — broad incumbent with overlapping fulfillment and consumer prescription offerings.

TypeEmerging player
Description

Online mail-order pharmacy offering transparent pricing and direct-to-consumer prescription delivery — emerging DTC pharmacy competitor with different value proposition but overlapping customer segment.

TypeEmerging player
Description

D2C telehealth and subscription pharmacy platform combining virtual consultations with prescription fulfillment — comparable integration of telehealth and pharmacy services in a consumer brand wrapper.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature1 record

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds13 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors4 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

NowRx

Digital Pharmacy and Prescription Delivery Servicesnowrx.com

NowRx was a Mountain View-based digital pharmacy offering same-day prescription delivery and telehealth services to individual healthcare consumers, having raised over $43 million via equity crowdfunding before being acquired by Alto Pharmacy in November 2022.

What NowRx does

NowRx was a digital pharmacy and last-mile logistics company founded in 2015 in Mountain View, California, that provided same-day and same-hour prescription medication delivery to individual consumers. The company combined a licensed pharmacy operation with proprietary delivery infrastructure, enabling direct-to-consumer fulfillment of prescriptions without requiring patients to visit a brick-and-mortar location. Its product portfolio comprised a core prescription delivery service and a Telehealth Service launched in 2021 that enabled virtual healthcare consultations, which experienced 1,200% growth in its first year. The technology platform integrated prescription management, telehealth consultations, and health information content delivery to consumers.

The company operated a direct-to-consumer go-to-market motion, targeting individual healthcare consumers seeking convenience over traditional pharmacy channels. Its revenue model was built on prescription fulfillment fees and telehealth service subscriptions. NowRx raised over $43 million in total funding primarily through equity crowdfunding on SeedInvest, with a Series C round of $18.6 million closed in May 2022 from over 6,100 retail investors. The company grew from $600,000 in revenue in 2016 to over $20 million by 2022, reaching 51-100 employees.

In November 2022, NowRx was acquired by Alto Pharmacy, a competing digital pharmacy, ending its independent operations. Multiple securities class action lawsuits filed in 2025 allege that NowRx concealed material adverse financial information, including near-bankruptcy and reduced valuation, from investors during its February-November 2022 Series C offering period.

NowRx firmographics

Firmographics
Name
NowRx
Legal name
Nowrx
Website
https://nowrx.com
Company type
Private
Founded year
2016
Operating status
Acquired
Headcount range
11–50 employees
Short description
NowRx was a Mountain View-based digital pharmacy offering same-day prescription delivery and telehealth services to individual healthcare consumers, having raised over $43 million via equity crowdfunding before being acquired by Alto Pharmacy in November 2022.
Ownership category
akta.pro rank

NowRx industry classification

Industry
Product category
Digital Pharmacy and Prescription Delivery Services
akta.pro industry
PRIMARYHLALABAL
Virtual Pharmacy & Medication Management Integration Platforms
Healthcare & Life Sciences/Telehealth Platforms/Provider-Integrated Virtual Care Platforms (Health Systems/Clinics)
SECONDARYHLALAAAD
Prescription-Based Digital Clinics (Condition-Specific Rx Programs)
Healthcare & Life Sciences/Telehealth Platforms/Direct-to-Consumer Virtual Care Platforms
SECONDARYHLACAKAG
Specialty Pharmacy & Complex Therapy Management Platforms
Healthcare & Life Sciences/Digital Health & Health IT/ePrescribing, Medication Management & Pharmacy IT

Keywords

  • Prescription delivery
  • Digital pharmacy
  • Telehealth services
  • Same-day delivery
  • Online pharmacy

Where NowRx is headquartered

Location

Headquarters

HQ city
Mountain View
HQ country
United States
HQ region
North America

Markets served

NowRx business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D, Supply Chain

Revenue model

  1. Prescription Pharmacy Services: Traditional pharmacy prescription fulfillment and delivery services to consumers
  2. Telehealth Services: Virtual healthcare consultations and services, experienced 1,200% growth in 2021

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

NowRx product offering

Product offering

Core offering

NowRx is a digital pharmacy and last-mile logistics company that provides same-day and same-hour prescription medication delivery directly to consumers. The company also operates a telehealth service enabling virtual healthcare consultations and prescription management, and publishes health information content covering medications, conditions, and wellness topics.

Product overview

NowRx operates primarily as a health information platform that provides educational content about medications, health conditions, and pharmacy services through its website. The platform publishes health articles and wellness guidance covering topics such as medication management, natural remedies, prescription refills, and various health conditions. The company also offers a telehealth service that launched in 2021 and experienced significant growth, enabling remote healthcare consultations. The product portfolio consists of the core health information website and the telehealth service offering.

Differentiator

Problem solved

Functional benefit

Products and services

  • NowRx Prescription Delivery Service Same-day and same-hour prescription medication delivery service providing direct-to-consumer home delivery of prescription medications, eliminating the need to visit a traditional brick-and-mortar pharmacy. Targeted at individual healthcare consumers seeking fast, accurate, and convenient prescription fulfillment.
  • NowRx Telehealth Service Telehealth service platform that enables remote virtual healthcare consultations and prescription management, providing a seamless digital experience that integrates with NowRx's prescription delivery offering. Designed for individual consumers needing virtual care and prescription access.
  • NowRx Health Information Platform Health information and insights platform publishing educational articles about medications, health conditions, wellness topics, natural remedies, and pharmacy services. Targeted at individual healthcare consumers seeking trusted health information and expert insights.

Quantifiable outcome

  • Revenue growth from $600,000 to over $20 million since 2016
  • +1 more outcomes

Companies that use NowRx

Customer profile

Segments1 record

Ideal customer profiles1 record

NowRx technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature1 record

NowRx partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Alto PharmacyminorOthersNowRx was acquired by Alto Pharmacy, a digital pharmacy company, announced in late 2022 period following the Series C offering and associated legal disputes.

Scale indicators4 records

Recent moves6 records

Expansion highlights4 records

NowRx competitors and assessment

Company assessment

Broad incumbents

  • Walgreens: Major US retail pharmacy with same-day prescription delivery in many markets — large incumbent competitor in pharmacy fulfillment with far greater scale and capital.
  • Amazon Pharmacy: Amazon's mail-order pharmacy service (including PillPack), providing prescription delivery at scale with Prime integration — a much larger incumbent pursuing the same digital pharmacy opportunity as NowRx.
  • CVS Pharmacy: Largest US retail pharmacy chain with home delivery and digital prescription services — broad incumbent with overlapping fulfillment and consumer prescription offerings.

Emerging players

  • Blink Health: Digital pharmacy offering prescription discounts and home delivery — comparable DTC prescription delivery and online pharmacy positioning.
  • Truepill: Digital pharmacy and telehealth infrastructure platform serving D2C health brands with fulfillment, telehealth, and pharmacy APIs — overlapping with NowRx's pharmacy + telehealth integration thesis.
  • Mark Cuban Cost Plus Drug Company: Online mail-order pharmacy offering transparent pricing and direct-to-consumer prescription delivery — emerging DTC pharmacy competitor with different value proposition but overlapping customer segment.
  • Hims & Hers Health: D2C telehealth and subscription pharmacy platform combining virtual consultations with prescription fulfillment — comparable integration of telehealth and pharmacy services in a consumer brand wrapper.

Direct peers

  • Capsule Pharmacy: Digital-first pharmacy offering free same-day delivery and a mobile-first prescription management experience; competes head-to-head with NowRx for DTC prescription customers in major US metros.
  • Alto Pharmacy: Acquirer of NowRx and a leading venture-backed digital pharmacy offering same-day delivery, pharmacist consultations, and integrated prescription management — directly comparable business model, customer base, and last-mile delivery infrastructure.
  • Medly Pharmacy: Digital pharmacy providing free same-day prescription delivery and telehealth-style pharmacist consultations in select US markets — closely comparable DTC model and customer experience to NowRx.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

NowRx social profiles

Digital presence

NowRx financial estimates

Financial estimate

Revenue estimate

Valuation estimate

NowRx leadership team

Management profile

Number of profiles

Profiles2 records

NowRx funding detail

Funding detail

Funding overview

Funding rounds13 records

Investors4 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

NowRx M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about NowRx

What does NowRx do?

NowRx is a digital pharmacy and last-mile logistics company that provides same-day and same-hour prescription medication delivery directly to consumers. The company also operates a telehealth service enabling virtual healthcare consultations and prescription management, and publishes health information content covering medications, conditions, and wellness topics.

Is NowRx a public or private company?

NowRx is a private company. It is classified as corporate owned and is currently acquired.

When was NowRx founded?

NowRx was founded in 2016. It employs 11 to 50 people.

Where is NowRx based?

NowRx is headquartered in Mountain View, United States, in the North America region.

How does NowRx make money?

Two revenue lines are on record. Prescription Pharmacy Services are the primary driver. The others are telehealth Services.

Who are NowRx's main competitors?

Broad incumbents on record are Walgreens, Amazon Pharmacy and CVS Pharmacy. Emerging players are Blink Health, Truepill, Mark Cuban Cost Plus Drug Company and Hims & Hers Health. Direct peers are Capsule Pharmacy, Alto Pharmacy and Medly Pharmacy.

Does NowRx have an API?

No public API is recorded for NowRx.

What industry is NowRx in?

NowRx's product category is Digital Pharmacy and Prescription Delivery Services. Its primary akta.pro industry code is HLALABAL, Virtual Pharmacy & Medication Management Integration Platforms, with a secondary code of HLALAAAD, Prescription-Based Digital Clinics (Condition-Specific Rx Programs).

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireINVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in NowRx, Inc. of Class Action Lawsuit and Upcoming DeadlinesPomerantz LLP filed a securities class action lawsuit against NowRx, Inc. alleging the company failed to disclose material adverse facts about its financial condition, including that it was near bankruptcy and had hired an investment bank to explore a sale. The complaint claims that NowRx's December 2021 valuation of $3.55 per share was significantly below the $10.50 per share offering price in its Series C stock offering in 2022, potentially exposing Series C investors to substantial losses. Investors have until January 23, 2026 to petition the court to serve as Lead Plaintiff for the class.GlobeNewswireINVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in NowRx, Inc. of Class Action Lawsuit and Upcoming DeadlinesA class action lawsuit has been filed against NowRx, Inc., alleging securities fraud and undisclosed financial troubles. The lawsuit highlights potential bankruptcy, scope of financial misrepresentation, and risks to investors in the company's Series C stock offering.PR NewswireBronstein, Gewirtz & Grossman LLC Urges NowRx, Inc. Investors to Act: Class Action Filed Alleging Investor HarmA class action lawsuit has been filed against NowRx, Inc. by Bronstein, Gewirtz & Grossman, LLC, alleging violations of federal securities laws concerning NowRx's financial condition and disclosures between February 1, 2022, and November 5, 2022.GlobeNewswireBronstein, Gewirtz & Grossman LLC Urges NowRx, Inc. Investors to Act: Class Action Filed Alleging Investor HarmBronstein, Gewirtz & Grossman, LLC filed a class action lawsuit against NowRx, Inc. and certain officers on December 15, 2025, alleging violations of federal securities laws during the class period of February 1, 2022 to November 5, 2022. The complaint alleges NowRx failed to disclose material adverse facts about its financial condition, including that it was near bankruptcy, had hired an investment bank to explore a sale, and that an independent valuation of $3.55 per share was significantly below the $10.50 per share offering price in the Company's Series C stock offering in 2022. Investors who purchased securities during this period are being encouraged to join the case, with a January 23, 2026 deadline to request lead plaintiff status.PR NewswireINVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in NowRx, Inc. of Class Action Lawsuit and Upcoming DeadlinesPomerantz LLP has filed a securities fraud class action lawsuit against NowRx, Inc. on behalf of investors who purchased the company's securities during the Class Period. The complaint alleges that NowRx failed to disclose material adverse facts about its financial condition, including that it was near bankruptcy and had hired an investment bank to explore a sale or raise funds. The lawsuit further alleges that NowRx's true valuation as of December 31, 2021 was $3.55 per share, significantly below the $10.50 per share offering price in its Series C stock offering in 2022, putting Series C investors at high risk of losing their investment. Investors have until January 23, 2026 to seek appointment as Lead Plaintiff in the class action.GlobeNewswirePortnoy Law Firm Announces Class Action on Behalf of NowRX, Inc. InvestorsThe Portnoy Law Firm announced a class action against NowRX, Inc. for investors who bought securities between February 1, 2022, and November 5, 2022. The lawsuit alleges the company failed to disclose its true financial condition and that it was close to bankruptcy, leading to losses for Series C Preferred Stock investors after its acquisition agreement with Alto Pharmacy.PR NewswireNOWRX INC. INVESTOR NOTICE: Squitieri Fearon LLP and Moore Law PLLC Announce that NowRx, Inc. Investors Have Opportunity to Lead Securities Class Action LawsuitSquitieri & Fearon LLP and Moore Law PLLC announced that investors of NowRx, Inc. have until January 23, 2026 to seek appointment as lead plaintiff in a securities class action lawsuit filed on November 4, 2025 in the Southern District of New York. The lawsuit alleges that NowRx and its executives sold Series C Preferred Stock at $10.50 per share during September 2021 while failing to disclose that the company was on the brink of bankruptcy and that an investment bank had valued NowRx at only $3.55 per share as of December 31, 2021. As a result of these alleged omissions, Series C stock investors lost their entire investment when NowRx's business was acquired by Alto Pharmacy in November 2022.